yingweiwo

ADCs

ADCs

ADCs related products

Structure Cat No. Product Name CAS No. Product Description
ABBV-011 V128025 ABBV-011 ABBV-011 is an antibody-drug conjugate (ADC) that targets SEZ6.
ADC Control Human IgG1-Deruxtecan (DAR 8) V97196 ADC Control Human IgG1-Deruxtecan (DAR 8) ADC Control Human IgG1-Deruxtecan (DAR 8) is a humanized monoclonal antibody that serves as an isotype control for the ADC Human IgG1-Deruxtecan, which inhibits DNA topoisomerase I.
ADC Control Human IgG1-DL-01 V128294 ADC Control Human IgG1-DL-01 ADC Control Human IgG1-DL-01 is an antibody-drug conjugate (ADC) consisting of the ADC antibody Human IgG1 lambda1, an isotype control, and the linker payload DL-01 formic acid.
ADC Control human IgG1-DM1 V103649 ADC Control human IgG1-DM1 ADC Control Human IgG1-DM1 is an ADC control consisting of human IgG1 kappa, isotype control, and linker-drug conjugate SMCC-DM1.
ADC Control Human IgG1-DM4 V103949 ADC Control Human IgG1-DM4 ADC Control Human IgG1-DM4 is the isotype control of ADC Human IgG1-DM4. The antibody part is Human IgG1 kappa, isotype control, and the ADC virulence molecule and linker part are SPDB-DM4.
ADC Control Human IgG1-ED04 V128295 ADC Control Human IgG1-ED04 ADC Control Human IgG1-ED04 is an ADC control consisting of human IgG1 kappa, isotype control, and ADC toxin ED04.
ADC Control Human IgG1-McMMAF V104022 ADC Control Human IgG1-McMMAF ADC Control Human IgG1-McMMAF is an antibody-drug conjugate (ADC) composed of the ADC antibody IgG1 human IgG1 kappa, isotype control, and payload McMMAF.
ADC Control Human IgG1-SN-38 V103948 ADC Control Human IgG1-SN-38 ADC Control Human IgG1-SN-38 is an isotype control for ADC Human IgG1-SN-38.
ADC Control Human IgG1-sulfo-SPDB-DM4 V116955 ADC Control Human IgG1-sulfo-SPDB-DM4 ADC Control Human IgG1-sulfo-SPDB-DM4 is an antibody-drug conjugate (ADC) that inhibits microtubule polymerization.
ADC Control Human IgG1-tirumotecan V117122 ADC Control Human IgG1-tirumotecan ADC reference standard human IgG1-tirumotecan is an antibody-drug conjugate (ADC).
ADC Control Human IgG1-vcMMAE (solution) V128296 ADC Control Human IgG1-vcMMAE (solution) ADC Control Human IgG1-vcMMAE (solution) is a humanized monoclonal antibody that serves as an isotype control of ADC human IgG1-vcMMAE and inhibits microtubule polymerization.
Anetumab ravtansine V128831 Anetumab ravtansine 1375258-01-7 Anetumab ravtansine is a highly selective and active antibody-drug conjugate (ADC) that targets maytansin-like microtubules.
Anti-CD22-NMS249 V94359 Anti-CD22-NMS249 Anti-CD22-NMS249 is a CD22-targeting antibody-drug conjugate (ADC) composed of the humanized anti-CD22 antibody Pinatuzumab, a cleavable linker (Mc-VC-PAB), and a DNA topoisomerase II inhibitor.
Atezolizumab-MMAE V129581 Atezolizumab-MMAE Atezolizumab-MMAE is an anti-PD-L1 antibody-drug conjugate (ADC) with an EC50 of 1.1 nM.
Azintuxizumab vedotin V129811 Azintuxizumab vedotin 1826819-58-2 Azintuxizumab vedotin is an antibody-drug conjugate (ADC) that targets a unique epitope of CD2 subset 1, a cell surface glycoprotein expressed on multiple myeloma cells.
BB-1701 V119061 BB-1701 BB-1701 is an anti-HER2 antibody-drug conjugate (ADC).
Becotatug vedotin V129979 Becotatug vedotin Becotatug vedotin is an antibody-drug conjugate (ADC) composed of the anti-EGFR humanized IgG1 monoclonal antibody Becotatug and MMAE.
Calotatug ginistinag V104014 Calotatug ginistinag 2847102-44-5 Calotatug ginistinag (XMT-2056) is a HER2-targeting antibody-drug conjugate linked to a payload consisting of a linker (XMT-1519 conjugate-1) and a STING agonist (STING agonist-20) with potential immune-activating and anti-tumor activities.
DS-3939a V118385 DS-3939a DS-3939a (DS-3939) is an antibody-drug conjugate (ADC) targeting TA-MUC1.
Emiltatug ledadotin V117291 Emiltatug ledadotin 2855974-40-0 Emiltatug ledadotin (Emi-Le; XMT-1660) is an antibody-drug conjugate (ADC) that targets B7-H4.
Contact Us